# Study to Assess Efficacy and Safety of Dupilumab in the Treatment of Keloids

> **NCT05128383** · PHASE2 · COMPLETED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 20 (actual)

## Conditions studied

- Keloid

## Interventions

- **DRUG:** Dupilumab

## Key facts

- **NCT ID:** NCT05128383
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-13
- **Primary completion:** 2025-05-19
- **Final completion:** 2025-06-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-08-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05128383

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05128383, "Study to Assess Efficacy and Safety of Dupilumab in the Treatment of Keloids". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05128383. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*